Information  X 
Enter a valid email address

Vectura Group PLC Ord 0.0271P (VEC)

Related News

30-Jul-2020 08:40 AM

Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC

Peel Hunt today reaffirms its buy investment rating on Vectura Group PLC (LON:VEC) and raised its price target to 134p (from 114p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Jan-2020 10:40 AM

Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC

Peel Hunt today upgrades its investment rating on Vectura Group PLC (LON:VEC) to buy (from hold). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Jan-2020 09:30 AM

Vectura sees earnings 'at least' in line with expectations

Inhaled therapy for respiratory diseases provider Vectura said it expected its annual revenue and adjusted operating earnings to be 'at least' in line with its expectations. R&D investment in 2020, meanwhile, was seen within a range of £4
06-Jan-2020 10:50 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Vectura Group PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Vectura Group PLC (LON:VEC) and raised its price target to 120p (from 110p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
24-Sep-2019 08:00 AM

Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC

Peel Hunt today reaffirms its hold investment rating on Vectura Group PLC (LON:VEC) and cut its price target to 114p (from 119p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
10-Sep-2019 01:27 PM

Vectura losses narrow; plans special dividend and share buyback

Asthma-treatment developer Vectura narrowed its first-half losses on the back of higher sales, while revealing plans for a special dividend and share buyback. Pre-tax losses for the six months through June amounted to £13.4m, compared to losses of
29-May-2019 08:03 AM

Vectura says trading in line; mulls 'material' shareholder returns

Pharmaceuticals company Vectura Group said its current outlook remained in line with its guidance for the full year and that it was considering returning capital to shareholders. 'We continue to focus on executing our strategy and build on the stron
09-May-2019 09:20 AM

Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC

Peel Hunt today reaffirms its hold investment rating on Vectura Group PLC (LON:VEC) and raised its price target to 119p (from 105p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Apr-2019 12:50 PM

Broker Forecast - JP Morgan Cazenove issues a broker note on Vectura Group PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Vectura Group PLC (LON:VEC) and cut its price target to 100p (from 110p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
26-Mar-2019 09:53 AM

Vectura posts annual loss after asthma treatment candidate disappoints

Pharmaceuticals company Vectura Group posted an annual loss after it wrote down the value of a potential asthma treatment that failed to perform as hoped during trials. Pre-tax losses for the year through December amounted to £104.8m, similar to lo
12-Mar-2019 09:40 AM

Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC

Peel Hunt today reaffirms its hold investment rating on Vectura Group PLC (LON:VEC) and cut its price target to 105p (from 107p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Jan-2019 07:56 AM

Vectura says 2018 earnings will beat market expectations

UK drug manufacturer Vectura said on Thursday it predicted its adjusted earnings in 2018 would "materially" exceed market expectations due to productivity initiatives and margin improvements. The company's revenue continued to grow in line
02-Jan-2019 08:30 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Vectura Group PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Vectura Group PLC (LON:VEC) and cut its price target to 110p (from 140p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Oct-2018 08:10 AM

Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC

Peel Hunt today reaffirms its hold investment rating on Vectura Group PLC (LON:VEC) and cut its price target to 107p (from 111p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
12-Sep-2018 02:00 PM

Broker Forecast - RBC Capital Markets issues a broker note on Vectura Group PLC

RBC Capital Markets today reaffirms its sector performer investment rating on Vectura Group PLC (LON:VEC) and cut its price target to 88p (from 92p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Jul-2018 08:50 AM

Broker Forecast - Shore Capital issues a broker note on Vectura Group PLC

Shore Capital today reaffirms its hold investment rating on Vectura Group PLC (LON:VEC) and cut its price target to 78p (from 105p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
17-May-2018 09:03 AM

Vectura revenues in line with expectations

Vectura, an inhaled product formulation, device design and development business, has confirmed its revenues are in line with its expectations for the full year. Growth in revenues continues to be driven by Vectura's key inhaled marketed products in
20-Apr-2018 01:50 PM

Broker Forecast - Shore Capital issues a broker note on Vectura Group PLC

Shore Capital today reaffirms its hold investment rating on Vectura Group PLC (LON:VEC) and set its price target at 105p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
19-Apr-2018 12:40 PM

Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC

Peel Hunt today reaffirms its hold investment rating on Vectura Group PLC (LON:VEC) and set its price target at 111p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
23-Mar-2018 09:50 AM

Broker Forecast - Peel Hunt issues a broker note on Vectura Group PLC

Peel Hunt today reaffirms its hold investment rating on Vectura Group PLC (LON:VEC) and cut its price target to 111p (from 120p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
22-Mar-2018 01:20 PM

Broker Forecast - Stifel issues a broker note on Vectura Group PLC

Stifel today reaffirms its buy investment rating on Vectura Group PLC (LON:VEC) and set its price target at 151p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
22-Mar-2018 12:30 PM

Broker Forecast - Numis issues a broker note on Vectura Group PLC

Numis today reaffirms its buy investment rating on Vectura Group PLC (LON:VEC) and set its price target at 160p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
21-Mar-2018 07:30 AM

Vectura Group losses more than double on asset write-downs

Inhalation device provider Vectura Group said annual losses more than doubled after it wrote down the value of past acquisitions and experienced delays launching a new asthma treatment. The company booked a pre-tax loss of £102.2m, compared to a &p
20-Mar-2018 08:50 AM

Broker Forecast - Citigroup issues a broker note on Vectura Group PLC

Citigroup today reaffirms its buy investment rating on Vectura Group PLC (LON:VEC) and set its price target at 155p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
12-Mar-2018 01:49 PM

Hikma Pharmaceutical loses dispute with FDA over asthma treatment

Hikma Pharmaceutical said a dispute resolution against the US Food and Drug Administration about the delayed launch of generic asthma treatment, VR315, had failed. The company said it now anticipated new clinical data for the treatment to be submitted &a
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t